Consolidated Statement Of Cash Flows

Mochida Pharmaceutical Co.,Ltd. - Filing #7300559

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
8,691,000,000 JPY
-5,517,000,000 JPY
Interest and dividends received
207,000,000 JPY
182,000,000 JPY
Income taxes paid
-370,000,000 JPY
-587,000,000 JPY
Net cash provided by (used in) operating activities
8,519,000,000 JPY
-5,930,000,000 JPY
Cash flows from investing activities
Purchase of securities
-3,000,000,000 JPY
-4,500,000,000 JPY
Proceeds from sale of securities
4,500,000,000 JPY
4,500,000,000 JPY
Proceeds from sale of property, plant and equipment
1,000,000 JPY
JPY
Purchase of investment securities
JPY
-300,000,000 JPY
Net cash provided by (used in) investing activities
9,658,000,000 JPY
-1,790,000,000 JPY
Proceeds from sale of investment securities
JPY
15,000,000 JPY
Other, net
4,000,000 JPY
14,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-1,000,000 JPY
-2,930,000,000 JPY
Dividends paid
-1,417,000,000 JPY
-1,462,000,000 JPY
Net cash provided by (used in) financing activities
-1,432,000,000 JPY
-4,399,000,000 JPY
Other, net
-13,000,000 JPY
-6,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
-45,000,000 JPY
67,000,000 JPY
Net increase (decrease) in cash and cash equivalents
16,700,000,000 JPY
-12,053,000,000 JPY
Cash and cash equivalents
40,991,000,000 JPY
24,290,000,000 JPY
25,957,000,000 JPY
38,010,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.